Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Freedom Leaf

JANUARY 10, 2018

We genetically develop [the strains] to improve patients’ symptoms and conditions,” Gardner explains. “In In that time, we’ve created the world’s largest database of clinical or observational data to understand the efficacy of these products for the symptom relief of the patients.” In the U.S., the efficacy of our strains.”

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Graham contributes to Psilocybin Alpha as editor-at-large, providing data for patent trackers and writing about IP in the psychedelics space. David Nutt. Drug Science.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

MARCH 3, 2020

With 150 different cannabinoids, over 300 terpenes, and more of each being discovered almost monthly, the product range and possibilities in this area are endless. The Company will hire or joint venture with other, already existing, labs to manufacture CBD, CBG, CBC, CBN, and other products in its future cannabinoid line. Watch as Hemp, Inc.,

Hemp 59

Hemp Seed-To-Sale Education Research and Development 59